Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/1999
11/02/1999US5977314 Catalytic antibodies against cocaine
11/02/1999US5977311 53BP2 complexes
11/02/1999US5977306 Therapeutic compositions to protect animals from diseases caused by parasitic helminths.
11/02/1999US5977304 Modification of pertussis toxin
11/02/1999US5977300 Isolated nonapeptide which bind to HLA-B44 molecules and the uses thereof
11/02/1999US5977299 Peptide having terminal activating group; for sensitive diagnostics; therapy
11/02/1999US5977151 Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
11/02/1999US5977085 Vectors carrying coding sequence for the SpsB protein of Staphylococcus aureus
11/02/1999US5977065 Bacterial nitroreductase for the reduction of CB1954 and analogues thereof to a cytotoxic form
11/02/1999US5977057 Administering tissue factor pathway inhbibitor
11/02/1999US5976896 Transferring mixture of sample and fluorescently labeled conjugate to tube with substrate-coated interior surface, incubating allowing binding, removing excess fluid, irradiating coated portions, detecting fluorescence
11/02/1999US5976895 A test kit for testing of fluid samples for drugs of abuse.
11/02/1999US5976891 Simple, inexpensive and accurate method using holder with first reactant absorbed on inner sides, adding solution of second reactant, irradiating holder, detecting change; for detecting binding between antibody and virus for diagnosis
11/02/1999US5976889 Gas analyzer and method for detecting NOx
11/02/1999US5976888 Method for measuring NOx in biochemical processes
11/02/1999US5976887 Complex of 2,4-diaminotoluene, 3,4-diaminotoluene or 2,3-diaminonaphthalene with soluble metal ion of gold (ii), chromium (vi), iron (iii), ruthenium (iii) and vanadium (v); for detection of by-products, pollution or markers
11/02/1999US5976885 Method for the detection of cellular abnormalities using infrared spectroscopic imaging
11/02/1999US5976883 Solvent extraction of soil sample using c2 or higher alcohol to form liquid and solid phases, irradiating liquid phase with ultraviolet radiation, measuring absorption, comparing to standards; simple method to identify aromatic impurites
11/02/1999US5976882 Rapid and accurate analysis of content by preparing calibration curve based on absorbance values from known food samples, then irradiating unknown food samples, measuring absorbance and calculating content
11/02/1999US5976881 Device and method for detecting chemical breakthrough of protective clothing
11/02/1999US5976873 Nucleic acid sequences controlling lung cell-specific gene expression
11/02/1999US5976862 Process for obtaining DNA, RNA, peptides, polypeptides, or proteins, by recombinant DNA technique
11/02/1999US5976852 Isolated nucleic acid molecule encoding a receptor protein; for identifying agonists and antagonists; treatment of paralytic disease; antitumor/antimetastasis agents
11/02/1999US5976849 Human E3 ubiquitin protein ligase
11/02/1999US5976835 Nucleic acids encoding receptor recognition factor Stat1α and Stat1β, and methods of use thereof
11/02/1999US5976834 cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor
11/02/1999US5976831 Therapeutic compounds, and more particularly to soluble and membrane-bound forms of a low-affinity receptor for human immunoglobulin g, nucleic acids encoding the same. diagnostic uses of such receptors.
11/02/1999US5976825 Drug screening process
11/02/1999US5976824 Method and apparatus for collecting a cell sample from a liquid specimen
11/02/1999US5976823 Acidic composition of indicator which interacts with free available chlorine, a buffer, nonionic and/or anionic surfactants, peroxidase and/or iodide ion, a polymer, water; for accurate and rapid analysis of hemodialysis rinse water
11/02/1999US5976822 Reagent of water soluble, physiologically acceptable, cell permeable salt; compound has leaving group for cleavage by cysteine protease, dipeptyl peptidase, and calpain and a fluorogenic indicator activated after cleavage
11/02/1999US5976820 Homogenous immunoassay for gram-negative bacteria by incubating antibody-containing sample fluid with purified fluorophore-conjugated oligosaccharide antigen, measuring fluorescence and comparing to negative control
11/02/1999US5976819 Screening for agents by contacting mature t lymphocyte with compound, stimulating t lymphocyte causing phosphorylation of tyrosine in specific motif, assessing ability of compound to regulate association between actin and motif
11/02/1999US5976818 Ca 125 is an antigenic determinant or epitope located on the surface of ovarian tumor cells with essentially no expression in normal adult ovarian tissue. however, ca 125 is expressed on the cell surface of tumor cells in culture and on ovarian
11/02/1999US5976817 Diagnostic method for detecting Alzheimer's disease in living patients
11/02/1999US5976816 Cell tests for alzheimer's disease
11/02/1999US5976815 Screening drugs/ligands of activin receptor-like kinase 7 receptor by transfecting host cell with nucleic acid encoding receptor protein, contacting cell with drug/ligand, evaluating effect on kinase activity
11/02/1999US5976813 Continuous format high throughput screening
11/02/1999US5976812 Amphetamine linked to maleimide; for immunogens and conjugates; for production of antibodies and detection of drugs of abuse
11/02/1999US5976811 Antibody which is prepared by immunizing animal with homopolymer of units of g-x-a where g is a bile acid, salt or ester, x is a bridge group and a is a polymerizable, ethenically unsaturated group
11/02/1999US5976810 Method of detecting autoantibody present in the serum of rheumatic
11/02/1999US5976809 Assay of free and complexed trypsinogen-2
11/02/1999US5976807 Eukaryotic cells stably expressing genes from multiple transfected episomes
11/02/1999US5976800 Enhancement of cancer cell death
11/02/1999US5976786 Screening methods for the identification of compounds that modulate apoptosis in immunodeficiency virus infected cells
11/02/1999US5976785 Competitive assays for determining the effectiveness of a human immunodeficiency virus type 2 (HIV-2) antiviral agent, employing peptides and proteins of HIV-2
11/02/1999US5976784 Calcitriol derivatives and their uses
11/02/1999US5976782 Screening substances for angiogenesis modulation activity.
11/02/1999US5976533 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
11/02/1999US5976529 Methods of enzyme therapy by orally administering crosslinked enzyme crystals
11/02/1999US5976527 High surface area support having bound latex particles containing oxirane groups for immobilization of substances
11/02/1999US5976525 Can be used to produce protective vaccines, such as inactivated whole cell or subunit vaccines, or for diagnostic purposes such as for the production of antibodies and detection of pathogenic enteric bacteria or to produce
11/02/1999US5976494 Technetium-99m labeled peptides for imaging
11/02/1999US5976466 Multiple-probe diagnostic sensor
11/02/1999US5976461 Method for protecting cooling water systems
11/02/1999US5976426 Latex of calibrated monodisperse magnetizable microspheres, process of preparation and use of the said latex in chemistry or in biology
11/02/1999US5976369 Magnetic separation apparatus
11/02/1999US5976085 In situ calibration system for sensors located in a physiologic line
11/02/1999US5976028 Golf club spine finder and method
11/02/1999US5974899 Soil nutrient extraction method using pressurized hot water
11/02/1999US5974868 Downstream monitor for CMP brush cleaners
11/02/1999US5974866 On-line rheometer device
11/02/1999US5974629 Method and apparatus for measuring fiber length and nep number in a carding machine
11/02/1999CA2171473C Quick biochemical oxygen demand test and apparatus for the same
11/02/1999CA2119443C Human cyclin e
11/02/1999CA2066263C Tsh receptor
11/02/1999CA2002788C Adp glucose-pyrophosphorylase
11/02/1999CA1340806C Method, system and reagents for dna sequencing
10/1999
10/30/1999CA2270809A1 Breath monitoring apparatus
10/30/1999CA2270754A1 Selection process for bacterial strain
10/28/1999WO1999054741A1 Paper stock zeta potential measurement and control
10/28/1999WO1999054739A1 Detection and determination of phenol-like substances by means of direct wet-chemical methods
10/28/1999WO1999054738A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof
10/28/1999WO1999054737A1 Immunodiagnostic method for granzymes
10/28/1999WO1999054736A1 Detection of very low quantities of analyte
10/28/1999WO1999054735A1 Improved immunodiagnostic assays using reducing agents
10/28/1999WO1999054734A1 Comb-like solid phase for measuring analytes
10/28/1999WO1999054733A1 Detection and diagnosis of conditions associated with lung injury
10/28/1999WO1999054732A1 IλB AND ENHANCED GREEN FLUORESCENT FUSION PROTEIN
10/28/1999WO1999054731A1 Method for amplifying the formation of ligand-receptor complexes and uses
10/28/1999WO1999054730A1 Method and device for carrying out a chemical analysis in small amounts of liquid
10/28/1999WO1999054729A2 Immobilized substrate, separation gels and method for detecting enzymatic activity
10/28/1999WO1999054728A2 Method of predicting receptor modulating activity
10/28/1999WO1999054727A1 Soil test
10/28/1999WO1999054726A1 Method and device for measuring the amount of ice glaze added to frozen foods
10/28/1999WO1999054725A1 Method for determining a gushing factor for a beverage
10/28/1999WO1999054724A1 Process for evaluating chemical and biological assays
10/28/1999WO1999054718A1 Biochemical devices and their methods of manufacture
10/28/1999WO1999054707A2 Fetal testing for prediction of low birth weight
10/28/1999WO1999054509A1 Methods for reducing non-specific binding to a nucleic acid probe array
10/28/1999WO1999054503A1 Simplified sequential chemiluminescent detection
10/28/1999WO1999054494A2 Multiparameter facs assays to detect alterations in cellular parameters
10/28/1999WO1999054493A2 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
10/28/1999WO1999054490A2 Plant-derived resistance gene
10/28/1999WO1999054473A2 Bacterial yjeq polypeptide family
10/28/1999WO1999054467A1 Sh2 domain-containing peptides
10/28/1999WO1999054465A2 Gene encoding syntaxin interacting protein
10/28/1999WO1999054464A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
10/28/1999WO1999054463A2 Human k+ ion channel and therapeutic applications thereof
10/28/1999WO1999054460A2 Human nucleic acid sequences of normal bladder tissue